Concepedia

Andrew Saati

AS

Statistics

Publications

6

Citations

277

H-Index

6

Active since

2006

Affiliations

Pfizer (United States)(Current)

Andrew Saati is an author at Pfizer (United States) specializing in biochemistry, antibody characterization, and life sciences.

Publications per year

2006–2019

6

Publications

6

NIST Interlaboratory Study on Glycosylation Analysis of Monoclonal Antibodies: Comparison of Results from Diverse Analytical Methods

Maria Lorna A. De Leoz, David L. Duewer, Adam Fung et al. · Molecular & Cellular Proteomics · 2019 · 125 citations · Full text

, , +17

Conjugated linoleic acid isomers reduce blood cholesterol levels but not aortic cholesterol accumulation in hypercholesterolemic hamsters

Thomas A. Wilson, Robert J. Nicolosi, Andrew Saati et al. · Lipids · 2006 · 46 citations

, , +15

Development and Application of a Robust N‐Glycan Profiling Method for Heightened Characterization of Monoclonal Antibodies and Related Glycoproteins

Tanya Q. Shang, Andrew Saati, Kelly N. Toler et al. · Journal of Pharmaceutical Sciences · 2014 · 39 citations

, , +17

Nonclinical Evaluation of PF-06438179: A Potential Biosimilar to Remicade® (Infliximab)

Mazin Derzi, Theodore R. Johnson, Ahmed Shoieb et al. · Advances in Therapy · 2016 · 36 citations · Full text

, , +12

Reactivity-driven cleanup of 2-Aminobenzamide derivatized oligosaccharides

An‐Hsiang Adam Chu, Andrew Saati, John J. Scarcelli et al. · Analytical Biochemistry · 2018 · 16 citations · Full text

, , +16

1–5 of 6